Financial Advisors’s Medtronic MDT Stock Holding History

Financial Advisors’s Portfolio MDT Stock Details MDT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-1,618	Closed	-$201K	–	89
2021 Q2	$201K	Buy	+1,618	New	+$203K	0.07%	87

Other funds holding MDT

WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Financial Advisors's MDT Position: Q3 2021 in Review

Financial Advisors sold out of Medtronic (MDT) in Q3 2021, closing a stake of 1,618 shares — an estimated $201K sold.

Financial Advisors first reported a position in MDT in Q2 2021 and held it in 1 quarter. The position peaked at $201K in Q2 2021. 2,023 funds tracked by Wall St. Rank hold MDT as of Q3 2021.

Financial Advisors reported no remaining Medtronic position as of Q3 2021 after selling out during the quarter.
Financial Advisors sold 1,618 Medtronic shares in Q3 2021, an estimated $201K.
Financial Advisors first reported a position in Medtronic in Q2 2021 and held it in 1 quarter.
Financial Advisors's Medtronic position peaked at $201K in Q2 2021.
2,023 funds tracked by Wall St. Rank held Medtronic as of Q3 2021.

Based on Financial Advisors's 13F filing for Q3 2021, filed 12 Nov 2021.